Literature DB >> 12406543

The role of human papillomavirus oncoproteins E6 and E7 in apoptosis.

Patrick Finzer1, Adriana Aguilar-Lemarroy, Frank Rösl.   

Abstract

The oncogenic potential of 'high risk' human papillomaviruses can be mainly attributed to two small proteins called E6 and E7. Even these oncoproteins have a low molecular size, they are highly promiscuous and are capable to interact with a whole variety of host cellular regulator proteins to elicit cellular immortalization and ultimately complete malignant transformation. To avoid reiterations in summarizing the biochemical and molecular biological properties of E6/E7 in terms of their influence on cell cycle control, the present review is mainly an attempt to describe some regulatory principles by which human papillomavirus (HPV) oncoproteins can interfere with apoptosis in order to escape immunological surveillance during progression to cervical cancer. The models derived from these basic cellular and molecular studies are relevant to our understanding of HPV-induced carcinogenesis. Conversely, experimental procedures aimed at relieving apoptosis resistance, can facilitate the eradication of immunologically suspicious cells and may prevent the accumulation of cervical intraepithelial cell abnormalities in future prophylactic or therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406543     DOI: 10.1016/s0304-3835(02)00431-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

1.  p53 and hTERT determine sensitivity to viral apoptosis.

Authors:  Marie L Nguyen; Rachel M Kraft; Martine Aubert; Edward Goodwin; Daniel DiMaio; John A Blaho
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 2.  Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.

Authors:  Niladri Ganguly
Journal:  Cell Oncol (Dordr)       Date:  2012-01-20       Impact factor: 6.730

Review 3.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

Review 4.  Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck.

Authors:  Grace C Blitzer; Molly A Smith; Stephen L Harris; Randall J Kimple
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-15       Impact factor: 7.038

5.  1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6.

Authors:  Yves Nominé; Sebastian Charbonnier; Laurent Miguet; Noelle Potier; Alain Van Dorsselaer; R Andrew Atkinson; Gilles Travé; Bruno Kieffer
Journal:  J Biomol NMR       Date:  2005-02       Impact factor: 2.835

6.  The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose.

Authors:  M Filippova; T A Brown-Bryan; C A Casiano; P J Duerksen-Hughes
Journal:  Cell Death Differ       Date:  2005-06-03       Impact factor: 15.828

Review 7.  Regulation of apoptosis by the papillomavirus E6 oncogene.

Authors:  Ting-Ting Li; Li-Na Zhao; Zhi-Guo Liu; Ying Han; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 8.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

9.  GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions.

Authors:  Grushenka H I Wolfgang; Riri Shibata; Jianying Wang; Adrian S Ray; Sylvia Wu; Edward Doerrfler; Hans Reiser; William A Lee; Gabriel Birkus; Neil D Christensen; Graciela Andrei; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

10.  Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Xuefeng Liu; Yuhai Dai; Dan P Hartmann; John Hanover; Richard Schlegel
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.